NunaBio
Latest round
- Seed
Last raised
- Mar 2023
Total raised
- $2.3M
Investors
- 4
About NunaBio
Based in the UK, and founded in 2021 by Joe Hedley (CEO), Eimer Tuite (CSO) and Andrew Pike (CTO), Nuna Bio is a biotechnology company that uses advanced analytics to create personalized treatment solutions for complex diseases such as cancer, autoimmune disorders, and neurological disorders. NunaBio is developing an advanced method for DNA synthesis that will enable the manufacturing of oligonucleotides with precision and speed. Furthermore, the company's platform will enable the creation of entire genes and DNA segments of unfamiliar length without the use of plasmids or primers, which are currently limiting factors in the field of synthetic biology. In addition, the firm's technology can be applied to various fields in life sciences, such as gene therapy, T-cell manipulation, viral vector creation, diagnosis, hybridization capture, and targeted biomarker identification. In April 2026, NunaBio Ltd.
Who invested in NunaBio
4 investors across 1 round
See all investors in NunaBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 7, 2023
Amount
$2.3M
Investors
Questions about NunaBio
Who invested in NunaBio?
NunaBio has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NunaBio raised?
NunaBio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NunaBio last raise money?
NunaBio's most recent round on record is a Seed, in Mar 2023.
What does NunaBio do?
Based in the UK, and founded in 2021 by Joe Hedley (CEO), Eimer Tuite (CSO) and Andrew Pike (CTO), Nuna Bio is a biotechnology company that uses advanced analytics to create personalized treatment solutions for complex diseases such as cancer, autoimmune disorders, and neurological disorders.
Where is NunaBio headquartered?
NunaBio is headquartered in Newcastle upon Tyne, UK.
Which VCs invest in companies like NunaBio?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at NunaBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like NunaBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.